Previous studies reported that the expression of PLCε was up-regulated in esophageal squamous cell carcinoma, renal cell carcinoma, and bladder cancer, correlating with tumor invasiveness and decreased patient survival, while its suppression inhibited the growth of and induced cell death in these cells [25,26,27]. The gene discussed is PLCE1; the disease is urinary bladder cancer.